BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 33160847)

  • 1. Utilization of renal mass biopsy in patients with localized renal cell carcinoma: A population-based study utilizing the National Cancer Database.
    Patel DN; Ghali F; Meagher MF; Javier-Desloges J; Patel SH; Soliman S; Hakimi K; Yuan J; Murphy J; Derweesh IH
    Urol Oncol; 2021 Jan; 39(1):79.e1-79.e8. PubMed ID: 33160847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilization of renal mass biopsy in patients with renal cell carcinoma.
    Leppert JT; Hanley J; Wagner TH; Chung BI; Srinivas S; Chertow GM; Brooks JD; Saigal CS;
    Urology; 2014 Apr; 83(4):774-9. PubMed ID: 24529579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contemporary trends in percutaneous renal mass biopsy utilization in the United States.
    Ozambela M; Wang Y; Leow JJ; Silverman SG; Chung BI; Chang SL
    Urol Oncol; 2020 Nov; 38(11):835-843. PubMed ID: 32912815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathological characteristics of the large renal mass: potential implication for clinical role of renal biopsy.
    Asghar AM; McIntosh AG; Smith ZL; Kocher NJ; Lee Z; Barashi NN; Li T; Raman JD; Eggener SE; Uzzo RG; Kutikov A
    Can J Urol; 2021 Apr; 28(2):10620-10624. PubMed ID: 33872561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding the role of percutaneous biopsy in the management of patients with a small renal mass.
    Tan HJ; Jacobs BL; Hafez KS; Montgomery JS; Weizer AZ; Wood DP; Miller DC; Wolf JS
    Urology; 2012 Feb; 79(2):372-7. PubMed ID: 22310755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does renal mass biopsy influence multidisciplinary treatment recommendations?
    Lobo JM; Clements MB; Bitner DP; Mikula MD; Noona SW; Sultan MI; Cathro HP; Lambert DL; Schenkman NS; Krupski TL
    Scand J Urol; 2020 Feb; 54(1):27-32. PubMed ID: 31868063
    [No Abstract]   [Full Text] [Related]  

  • 7. Association between renal mass biopsy and upstaging to perinephric fat involvement in a contemporary cohort of patients with clinical T1a renal cell carcinoma.
    Salmasi A; Faiena I; Lenis AT; Pooli A; Johnson DC; Drakaki A; Gollapudi K; Blumberg J; Pantuck AJ; Chamie K
    Urol Oncol; 2018 Dec; 36(12):527.e13-527.e19. PubMed ID: 30228094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal mass biopsy: A strategy to reduce associated costs and morbidity when managing localized renal masses.
    Srivastava A; Uzzo RN; Lee J; Cho E; Grieco A; Masic S; Handorf E; Chen DYT; Viterbo R; Greenberg RE; Smaldone MC; Kutikov A; Uzzo RG
    Urol Oncol; 2021 Nov; 39(11):790.e9-790.e15. PubMed ID: 34301455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial nephrectomy is not associated with an overall survival advantage over radical nephrectomy in elderly patients with stage Ib-II renal masses: An analysis of the national cancer data base.
    Ristau BT; Handorf EA; Cahn DB; Kutikov A; Uzzo RG; Smaldone MC
    Cancer; 2018 Oct; 124(19):3839-3848. PubMed ID: 30207380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilization and Operative Influence of Renal Mass Biopsy in the Small Renal Mass: Analysis from the Clinical Research Office of the Endourological Society Small Renal Mass registry.
    Shahait M; Jackman S; Landman J; Lechevallier E; Billiet I; Fossion L; Aslan Y; Laguna MP
    J Endourol; 2020 Jan; 34(1):99-106. PubMed ID: 31559847
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses.
    Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
    Eur Urol; 2015 Feb; 67(2):252-9. PubMed ID: 25108580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Under-grading of <4 cm renal masses on renal biopsy.
    Harris CR; Whitson JM; Meng MV
    BJU Int; 2012 Sep; 110(6):794-7. PubMed ID: 22404857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequencing of Renal Mass Biopsy and Ablation: Results from the National Cancer Database.
    Uhlig A; Lenis A; Wang X; Shuch B
    Urol Pract; 2021 Sep; 8(5):555-564. PubMed ID: 37145397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolving Trends for Selected Treatments of T1a Renal Cell Carcinoma.
    Doolittle J; Piotrowski J; Zuk K; Jacobsohn K; Langenstroer P; See W; Johnson S
    Urology; 2019 Oct; 132():136-142. PubMed ID: 31279691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thermal ablation vs surgery for localized kidney cancer: a Surveillance, Epidemiology, and End Results (SEER) database analysis.
    Choueiri TK; Schutz FA; Hevelone ND; Nguyen PL; Lipsitz SR; Williams SB; Silverman SG; Hu JC
    Urology; 2011 Jul; 78(1):93-8. PubMed ID: 21550636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utilization of Renal Mass Biopsy for T1 Renal Lesions across Michigan: Results from MUSIC-KIDNEY, A Statewide Quality Improvement Collaborative.
    Patel AK; Lane BR; Chintalapati P; Fouad L; Butaney M; Budzyn J; Johnson A; Qi J; Schervish E; Rogers CG
    Eur Urol Open Sci; 2021 Aug; 30():37-43. PubMed ID: 34337546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of guideline recommended use of renal mass biopsy and association with treatment.
    Michel J; Lenis AT; Lec PM; Golla V; Johnson DC; Gollapudi K; Blumberg J; Shuch BM; Chamie K
    Can J Urol; 2020 Aug; 27(4):10285-10293. PubMed ID: 32861253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncocytoma on renal mass biopsy: is it still the same histology when surgery is performed? Results from UroCCR-104 study.
    Branger N; Bigot P; Pignot G; Lorusso V; Audenet F; Parier B; Doumerc N; Brenier M; Xylinas E; Boissier R; Rouprêt M; Champy C; Nouhaud FX; Lang H; Charles T; Mallet R; Ambrosetti D; Bensalah K; Bernhard JC
    World J Urol; 2023 Feb; 41(2):483-489. PubMed ID: 36633650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncological outcomes of minimally invasive partial versus minimally invasive radical nephrectomy for cT1-2/N0/M0 clear cell renal cell carcinoma: a propensity score-matched analysis.
    Simone G; Tuderti G; Anceschi U; Papalia R; Ferriero M; Misuraca L; Minisola F; Mastroianni R; Costantini M; Guaglianone S; Sentinelli S; Gallucci M
    World J Urol; 2017 May; 35(5):789-794. PubMed ID: 27578234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2017 AUA Renal Mass and Localized Renal Cancer Guidelines: Imaging Implications.
    Ward RD; Tanaka H; Campbell SC; Remer EM
    Radiographics; 2018; 38(7):2021-2033. PubMed ID: 30339517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.